Alkem gets 8 observations from UKMHRA for Taloja plant
New Delhi : Drug firm Alkem Laboratories said UK health regulator has made eight observations after inspecting its manufacturing plant at Taloja, Maharashtra.
The Medicines and Healthcare Products Regulator Agency (UKMHRA) had conducted an inspection at the company's facility at Taloja earlier this month with respect to marketing authorisation applications made by the company to the EU countries.
"The company has received inspection report from the UKMHRA on March 30 where eight observations have been made by the regulator. The company is in the process of putting together responses to address observations made by the UKMHRA in the report," Alkem Laboratories said in a regulatory filing.
The company will submit the responses within the timeline stipulated by the UKMHRA, it added.
"The company does not anticipate any impact on its existing registered products in the EU market," it said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd